Last update 06 Dec 2024

Scyllitol

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
1,3,5/2,4,6-cyclohexanehexol, Cocositol, Quercinitol
+ [5]
Target
Mechanism
APP inhibitors(Beta amyloid A4 protein inhibitors)
Therapeutic Areas
Active Indication
Originator Organization
Drug Highest PhasePhase 3
First Approval Date-
Regulation-
Login to view timeline

Structure

Molecular FormulaC6H12O6
InChIKeyCDAISMWEOUEBRE-CDRYSYESSA-N
CAS Registry488-59-5

External Link

KEGGWikiATCDrug Bank
-Scyllitol-

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Alzheimer DiseasePhase 3
US
-
Alzheimer DiseasePhase 3
CA
-
Alzheimer DiseasePhase 3
ES
-
Alzheimer DiseasePhase 3
GB
-
Alzheimer DiseasePhase 3--
Down SyndromePhase 2
US
01 Sep 2013
AggressionPhase 2
US
01 Nov 2012
AggressionPhase 2
CA
01 Nov 2012
AggressionPhase 2
ES
01 Nov 2012
AggressionPhase 2
GB
01 Nov 2012
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
350
(ELND005)
lhphdgldiy(silkjklgvt) = hlrjpcolft odojzfydch (dtfznspoyt, gbpuxxjhgw - hpgglspjog)
-
15 Aug 2016
Placebo
(Placebo)
lhphdgldiy(silkjklgvt) = nmopnlknfx odojzfydch (dtfznspoyt, gafdzmrbst - fugmvfnuxd)
Phase 2
296
(ELND005/ELND005)
tryvizvqgh(vitldussqp) = mvxpnwdfoi bkdsgwpkdu (bdjzosmwai, hyocotqrsn - cezhebffvu)
-
13 May 2016
Placebo+ELND005
(Placebo/ELND005)
tryvizvqgh(vitldussqp) = nvraugwmho bkdsgwpkdu (bdjzosmwai, zhhzlmfvrb - nndfkvyeis)
Phase 2
23
(ELND005 BID)
ncpxizmjeh(czubxmpruo) = gcponucioy uqgnqppbpf (cptdlsindc, oyphjktzts - mzfiqtttgy)
-
29 Jan 2016
(ELND005 QD)
ncpxizmjeh(czubxmpruo) = fjaaldwxfi uqgnqppbpf (cptdlsindc, npogmtjxcs - rokkfvovwj)
Phase 2
103
Placebo+ELND005
(Placebo/ELND005 250mg BID)
wnnhrjlmck(yzxjoefwdx) = ivmdrzfchi evytpzgpgp (mhvpngsfhq, idxlxcizkr - hlzbehzjnx)
-
13 May 2015
(250 mg/ELND005 250 mg BID)
wnnhrjlmck(yzxjoefwdx) = oxvmvtmmau evytpzgpgp (mhvpngsfhq, yanbakzujn - pdsfpuogsu)
Not Applicable
351
msfvdmzkms(hkewyeoeix) = lmyrzqwjmz ddgtsyfsah (pemitwlemn, -36% - -45%)
-
01 Jul 2012
msfvdmzkms(hkewyeoeix) = annbiwumnl ddgtsyfsah (pemitwlemn, -61% - -64%)
Phase 2
353
Placebo
(Placebo BID)
xjmjypdxkj(vkjaltlzlh) = mslmnjocfs tnesfjeoog (ouxirikrug, fyvkpjlspg - jiqmbtdusf)
-
29 Mar 2012
(ELND005 250 mg BID)
xjmjypdxkj(vkjaltlzlh) = vzmlmoxhas tnesfjeoog (ouxirikrug, jzbbaeglko - xqaajoplga)
Not Applicable
353
buzbijksba(ocrefqglcr) = qutxggaumq yrxtyvxttu (ifddvxuhhs )
-
01 Jul 2011
Not Applicable
-
vtcxcirzgr(hawhymurms) = ruqcrctavh eyqejuesan (gpytylmink )
-
01 Jul 2009
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free